Screener
Climb Bio, Inc. CLYM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $8,356 | $35,685 |
| Short-term marketable securities | 101,208 | 65,395 |
| Prepaid expenses and other current assets | 3,840 | 4,769 |
| Total current assets | 113,404 | 105,849 |
| Long-term marketable securities | 36,741 | 59,572 |
| Operating lease right-of-use assets | 447 | 505 |
| Property and equipment, net | 250 | 288 |
| Other long-term assets | 1,530 | 1,530 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s total current assets?
- Climb Bio, Inc. (CLYM) reported total current assets of $113.4M in Q1 2026.
- How has Climb Bio, Inc.'s total current assets changed year-over-year?
- Climb Bio, Inc.'s total current assets increased by 13.1% year-over-year, from $100.28M to $113.4M.
- What is the long-term trend for Climb Bio, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s total current assets has grown at a 36.9% compound annual growth rate (CAGR), from $22M to $105.85M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Climb Bio, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude